The independent source for health policy research, polling, and news.
961-980 of 3,717 results
This episode is the second half of a two-part series about uranium mining on the Navajo Nation. A coalition of Indigenous leaders and non-Native locals are lobbying Congress and fielding research to force the cleanup of abandoned uranium mining sites and expand federal compensation for workers harmed by the uranium industry.
Inoculation rates remain low despite massive outreach efforts and incentives from federal and state programs and Medicaid plan operators, leaving many low-income people vulnerable to the virus.
A new investment fund launched by one of the few Black venture capitalists in health care is focused on backing Black entrepreneurs. And the investors include some of the biggest names in for-profit health care.
Montana has yet to start spending nearly $2.5 million in federal aid to boost covid detection and mitigation in the state’s prison and jails.
Clinical trials of covid-19 vaccines excluded pregnant people, which left many women wondering whether to get vaccinated.
KHN gives readers a chance to comment on a recent batch of stories.
Those who are living with disabilities, chronic illnesses or are immunocompromised because of medications or cancer treatment feel that their needs are not being considered as states open back up and lift mask mandates.
The spread of the omicron variant has dashed the hopes of many older adults that the country was exiting the worst of the pandemic, leaving them anxious while their patience wears thin.
California’s homeless crisis is often understood through cities like Los Angeles and San Francisco, where the sheer number of people living unsheltered can quickly capsize the programs designed to help them. But in remote counties like Del Norte, California’s Project Homekey is having a tangible impact.
Nicolas Montero is 16, and that’s old enough to get a vaccine on his own in Philadelphia. Vaccine regulations vary around the country and, in more than a dozen states, teens can consent to their own medical care.
Localities in California and Colorado are contracting with private companies to create their own health departments, spurred by a disregard for regional covid safety mandates.
Conservative lawmakers may find their anti-abortion agendas complicated by state constitutions that explicitly grant citizens the right to privacy, regardless of what the U.S. Supreme Court does.
A mother-and-daughter team went comparison-shopping to see what grocery store shelves revealed about inequity in America.
State medical boards have an obligation to investigate complaints about doctors, including those who may spread false information about medical care. But in Florida, Tennessee, and other states, lawmakers are moving to protect physicians using unproven covid treatments or spreading misinformation.
Episode 3 is an exploration of the forces that brought uranium mining to the Navajo Nation, the harmful consequences, and the fight for compensation that continues today.
Among many Latinos, especially recent immigrants, there is a cultural emphasis on living in harmony within one’s community — called “convivir” in Spanish. That notion may have helped drive improvements in covid vaccination and testing rates.
KHN highlights some of the creative valentines posted on Twitter by health policy enthusiasts.
Inquiries lead from one federal office to the next, with no clear answers. At one Army Contracting Command, a protocol office employee says that “voicemail has been down for months.” And the email address listed for fielding media inquiries? “The army stopped using the email address about eight years ago.”
Schools that serve poor and disadvantaged kids have taken a series of hits during the pandemic. Now, teachers of color are leaving the profession at higher rates than are white teachers.
Congress is set to start its once-every-five-years review of the law that authorizes user fees to finance the hiring of personnel to speed the FDA review of drugs. The periodic renewals of “PDUFA” also give lawmakers a chance to make other changes to the agency at the hub of the pandemic. Meanwhile, the FDA could also find itself at the center of the abortion debate and a controversial new medication to treat Alzheimer’s disease. Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more.
© 2026 KFF